Uncategorized

Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tablets because of nitrosamine impurity

Posted on

Last updated: 2019-04-18 OTTAWA – Health Canada is advising Canadians that Auro Pharma Inc. is voluntarily recalling one lot of Auro-Irbesartan/hydrochlorothiazide (HCT) combination tablets because of a nitrosamine impurity, N-nitrosodiethylamine (NDEA). The affected lot was released in August 2018 and distributed only in Ontario and Quebec. NDEA is classified as a probable human carcinogen, which […]

Uncategorized

Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory

Posted on

Last updated: 2019-04-16 OTTAWA – Health Canada is informing Canadians that the prescribing and patient information for Mifegymiso has been updated to reflect that an ultrasound is no longer required before the drug is prescribed. Mifegymiso is a combination product containing two drugs (mifepristone and misoprostol) that are taken in sequence for the medical termination […]

Uncategorized

Watchdogs Cite Lax Medical And Mental Health Treatment Of ICE Detainees

Posted on

It’s Saturday morning and the women of the Contreras family are busy in Montclair, Calif., making pupusas, tamales and tacos. They’re working to replace the income of José Contreras, who has been held since last June at Southern California’s Adelanto ICE Processing Center, a privately run immigration detention center. José’s daughter, Giselle, drives around in […]